Butterfly Network, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Butterfly Network, Inc. (NYSE: BFLY) develops, manufactures, and commercializes handheld ultrasound-on-chip technology and related software solutions for point-of-care medical imaging. The company offers whole-body ultrasound probes including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet; cloud-based software such as Compass for enterprise workflow integration, TeleGuidance, and AI-powered tools for image guidance and interpretation; educational platforms comprising in-app tutorials, ScanLab app, Butterfly Academy courses, and Butterfly Certified programs; and professional services for large-scale deployments. Butterfly Network, founded in 2011 and headquartered in Burlington, Massachusetts, operates primarily in the United States with international sales in regions including Europe, Asia, Africa, Australia, Indonesia, the Netherlands, and Belgium, targeting healthcare professionals, hospitals, clinics, veterinary practices, health systems, and medical education programs. In recent developments, the company launched the iQ3 ultrasound probe gaining traction in the U.S. and Europe with 55% product revenue growth; formed Octiv as a wholly-owned subsidiary to extend its Ultrasound-on-Chip technology into new sectors; expanded into new markets including Indonesia, the Netherlands, and Belgium driving 36% international revenue increase; initiated a Butterfly HomeCare pilot for AI-powered chronic care management with a Medicare Advantage provider; raised $75.6 million in post-IPO equity funding in January 2025 to enhance product lines and enter additional markets; and reported 5% revenue growth in Q3 2025 alongside advancements in AI tools for aortic valve imaging and gestational age assessment.
Butterfly Network to Participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026
Butterfly Network to Participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026
Butterfly Network, Inc. (BFLY) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference
Butterfly Network, Inc. (BFLY) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Has Butterfly Network (BFLY) Outpaced Other Medical Stocks This Year?
Butterfly Network Appoints Caroll H. Neubauer to Board of Directors
Butterfly Network to Present at the Bank of America Securities 2026 Global Healthcare Conference
Butterfly Network, Inc. (BFLY) Q1 2026 Earnings Call Transcript
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Beats Revenue Estimates
Butterfly Network Reports First Quarter 2026 Financial Results
Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard
Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS
Strength Seen in Butterfly Network (BFLY): Can Its 8.9% Jump Turn into More Strength?
Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026
BFLY's Blind-Sweep Ultrasound AI Tool for Gestational Age Wins FDA Nod
Butterfly Network gets FDA clearance for AI ultrasound pregnancy tool
Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health
The Future Is Now: 2 Medical Diagnostic AI Stocks to Snap Up